Blue Owl Capital Holdings »

Aeon Biopharma shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Aeon Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 3.3M 1.05

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Aeon Biopharma

Atalaya Capital Management
Polar Securities
Blue Owl Capital Holdings
Vanguard Group
BBK Capital Partners
BlackRock
BlackRock
Ikarian Capital
Geode Capital Management
Bank of America Corporation
Davidson Kempner Capital Management
Caprock
State Street Corporation
Northern Trust
LMR Partners

View all funds holding Aeon Biopharma